Y-Intercept (HK)’s Amneal Pharmaceuticals AMRX Stock Holding History

Y-Intercept (HK)’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.53M	Buy	88,143 +77,227	+707%	+$1.06M	0.03%	850
2026 Q1	$136K	Buy	+10,916	New	+$147K	﹤0.01%	1453
2025 Q1	–	Sell	-58,111	Closed	-$460K	–	1168
2024 Q4	$460K	Buy	58,111 +20,686	+55%	+$174K	0.03%	766
2024 Q3	$311K	Buy	+37,425	New	+$293K	0.02%	1002
2024 Q2	–	Sell	-28,123	Closed	-$170K	–	1361
2024 Q1	$170K	Buy	+28,123	New	+$159K	0.01%	1191
2023 Q4	–	Sell	-105,098	Closed	-$444K	–	1206
2023 Q3	$444K	Buy	105,098 +92,948	+765%	+$347K	0.04%	609
2023 Q2	$37.7K	Buy	+12,150	New	+$25.9K	﹤0.01%	1209

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Y-Intercept (HK)'s AMRX Position: Q2 2026 in Review

Y-Intercept (HK) increased its Amneal Pharmaceuticals (AMRX) stake by 707% in Q2 2026, buying an estimated $1.06M and bringing the position to 88,143 shares worth $1.53M. The position accounts for 0.03% of the portfolio, ranked #850.

Y-Intercept (HK) first reported a position in AMRX in Q2 2023 and has held it in 7 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Y-Intercept (HK) held 88,143 shares of Amneal Pharmaceuticals worth $1.53M as of Q2 2026.
Y-Intercept (HK) bought 77,227 Amneal Pharmaceuticals shares in Q2 2026, an estimated $1.06M.
Amneal Pharmaceuticals made up 0.03% of Y-Intercept (HK)'s portfolio in Q2 2026, its #850 holding.
Y-Intercept (HK) first reported a position in Amneal Pharmaceuticals in Q2 2023 and has held it in 7 quarters since.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.